Biohaven (BHVN) Research & Development (2021 - 2026)

Biohaven (BHVN) has 6 years of Research & Development data on file, last reported at $103.8 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 44.65% year-over-year to $103.8 million; the trailing twelve-month figure through Mar 2026 stood at $272.0 million (down 67.13% YoY), and the FY2025 full-year result was $635.1 million, down 20.21% from the prior year.
• Research & Development improved to $103.8 million in Q1 2026, from $12.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $314.8 million in Q2 2024 to a low of $4.2 million in Q4 2022.
• A 5-year average of $113.7 million and a median of $103.8 million in 2026 frame the typical range for Research & Development.
• Across the five-year window, Research & Development jumped 3075.81% in 2023 and sank 95.24% in 2025, its largest moves.
• Tracing BHVN's Research & Development over 5 years: stood at $4.2 million in 2022, then jumped by 3075.81% to $134.8 million in 2023, then increased by 24.23% to $167.5 million in 2024, then sank by 92.83% to $12.0 million in 2025, then soared by 765.22% to $103.8 million in 2026.
• Business Quant data shows BHVN's Research & Development at $103.8 million in Q1 2026, $12.0 million in Q4 2025, and $141.2 million in Q3 2025.